company highlights

Founded in 2018, Amcyte Pharma develops and commercializes cost-effective means of supporting and regulating the immune system. The company aims to leverage its team’s extensive immunology expertise, clinical experience and biologics manufacturing know-how to become a leading provider of healthcare solutions for patients suffering from immunologic and inflammatory diseases.

We partner with academic institutions and biotechnology companies to develop and commercialize cytokines and immunomodulators for therapeutic indications as well as adjuvants to cell therapy treatments.

Amcyte’s partners include Akron Biotechnology, a leading provider of ancillary materials produced under Good Manufacturing Practices (GMP) for the regenerative medicine industry, and Laboratorio Pablo Cassara S.R.L. (LPC) a pharmaceutical company with more than 20 years of experience in the manufacturing and production of pharmaceutical-grade IL-2 and other cytokines.

Amcyte develops and comercializes cost-effective means of supporting and regulating the immune system